2013

Mesalazine in UC, one or two doses/day

Certolizumab in CD

Safety and Tolerability of Low-dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease A Pilot Study

Azathioprine vs conventional therapy in CD

Thalidomide in paediatric CD

A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn’s disease

Azathioprine vs infliximab in postoperative recurrence in CD

AZA +/-METRO in postop recurrence in CD

Azathioprine vs in newly diagnosed CD